Search results for "thiadiazole"
showing 10 items of 79 documents
CCDC 671787: Experimental Crystal Structure Determination
2007
Related Article: G.E.Cami, M.L.Gonzalez, F.S.Ruiz, J.C.Pedregosa|2005|J.Phys.Chem.Solids|66|936|doi:10.1016/j.jpcs.2004.11.004
CCDC 140608: Experimental Crystal Structure Determination
2001
Related Article: E.Borras, G.Alzuet, J.Borras, J.Server-Carrio, A.Castineiras, M.Liu-Gonzalez, F.Sanz-Ruiz|2000|Polyhedron|19|1859|doi:10.1016/S0277-5387(00)00474-5
CCDC 1062665: Experimental Crystal Structure Determination
2015
Related Article: Christian F. Herold, Luca M. Carrella, Eva Rentschler|2015|Eur.J.Inorg.Chem.||3632|doi:10.1002/ejic.201500483
CCDC 737325: Experimental Crystal Structure Determination
2010
Related Article: A.Hangan, A.Bodoki, L.Oprean, G.Alzuet, M.Liu-Gonzalez, J.Borras|2010|Polyhedron|29|1305|doi:10.1016/j.poly.2009.12.030
A new tetranuclear copper(I) complex based on allyl(5-phenyl-1,3,4-thiadiazol-2-yl)azanide ligand: Synthesis and structural characterization
2015
Abstract By means of alternating current electrochemical technique a new tetranuclear crystalline copper(I) complex [Cu I 4 ( L − ) 4 ] ( L − – allyl(5-phenyl-1,3,4-thiadiazol-2-yl)azanide ion) has been obtained and characterized by X-ray single crystal diffraction ( Sp. gr. I 4 1 / a ) and Raman spectroscopy. The metal center adopts linear arrangement, composed of one thiadiazole N atom from the one L − anion and one azanide N atom of the other L − ligand. A bridged Cu atoms stitch four L − ligands into the firstly observed tetranuclear copper(I) azanide complex with intramolecular Cu(I)⋯Cu(I) interactions at the distance of 2.7451(6) A. Molecular structure and Raman spectrum of the compo…
Chemistry of Fluorinated Oxadiazoles and Thiadiazoles
2014
A literature survey of the chemistry of fluorinated oxadiazoles and thiadiazoles is presented. The core part on synthetic procedures is given by type of heterocycle and includes recent developments up to the end of 2012. Reactivity is discussed when induced by the presence of the fluorinated moiety. Selected examples of bioactive compounds and applications are illustrated.
Multiple 1,2,3-thiadiazoles
1997
A series of compounds 3a-d,i-n with two or three 1,2,3-thiadiazole rings, useful for photocrosslinking processes, was prepared from the di- or triketones 1a-d,i-n via the corresponding hydrazones 2a-d,i-n by applying the Hurd-Mori method. A special synthetic sequence, 1e, 2e, 3e, 3f/3g, was elaborated for the olefinic system 3h.
3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma
2020
A new series of imidazo[2,1-b][1,3,4]thiadiazole derivatives was efficiently synthesized and screened for their in vitro antiproliferative activity on a panel of pancreatic ductal adenocarcinoma (PDAC) cells, including SUIT-2, Capan-1 and Panc-1. Compounds 9c and 9l, showed relevant in vitro antiproliferative activity on all three pre-clinical models with half maximal inhibitory concentration (IC50) ranging from 5.11 to 10.8 µ
Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole derivatives: as anticancer and antibiofilm agents, and preclinical invest…
2020
3-(6-Phenylimidazo [2,1-
2019
A new series of imidazo[2,1-b][1,3,4]thiadiazole derivatives was efficiently synthesized and screened for their in vitro antiproliferative activity on a panel of pancreatic ductal adenocarcinoma (PDAC) cells, including SUIT-2, Capan-1 and Panc-1. Compounds 9c and 9l, showed relevant in vitro antiproliferative activity on all three pre-clinical models with half maximal inhibitory concentration (IC50) ranging from 5.11 to 10.8 µM, while the compounds 9e and 9n were active in at least one cell line. In addition, compound 9c significantly inhibited the migration rate of SUIT-2 and Capan-1 cells in the scratch wound-healing assay. In conclusion, our results will support further studies to increa…